An open-label pilot study of quetiapine addition to Oros methylphenidate in the treatment of ADHD [attention-deficit hyperactivity disorder] and high-aggression disruptive behavior disorders

Trial Profile

An open-label pilot study of quetiapine addition to Oros methylphenidate in the treatment of ADHD [attention-deficit hyperactivity disorder] and high-aggression disruptive behavior disorders

Completed
Phase of Trial: Phase II

Latest Information Update: 15 May 2015

At a glance

  • Drugs Methylphenidate; Quetiapine
  • Indications Attention-deficit hyperactivity disorder; Behavioural disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Apr 2009 Status changed from active, no longer recruiting to completed Last checked against ClinicalTrials.gov record.
    • 08 Apr 2009 Status changed from active, no longer recruiting to completed Last checked against ClinicalTrials.gov record.
    • 31 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top